Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 17 | Next »

1

Journal article

Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double‐blind, placebo‐controlled feasibility trial

Desborough, MJR, Laing, E, Kounali, D, et al.
2024-06-16

2

Journal article

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US

Li, X, Burn, E, Duarte-Salles, T, et al.
2022-10-26

3

Journal article

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales

Torabi, F, Bedston, S, Lowthian, E, et al.
2022-09-30

4

Journal article

Familial thrombocytopenia: the long and short of it

Murphy, L, Mead, AJ
2021-06-07

5

Journal article

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Simpson, CR, Shi, T, Vasileiou, E, et al.
2021-06-09

6

Journal article

Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)

Estcourt, LJ
2019-03-11

7

Journal article

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study

Estcourt, L, Stanworth, S, Harrison, P, et al.
2014-05-05

8

Journal article

Thrombocytopenia impairs host defense against Burkholderia pseudomallei (Melioidosis)

Birnie, E, Claushuis, T, Koh, G, et al.
2018-10-11

9

Journal article

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis

Birnie, E, Koh, G, Löwenberg, E, et al.
2017-03-15

10

Journal article

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Mesa, R, Vannucchi, A, Mead, A, et al.
2017-03-20

TO TOP